We are deeply honored to have Mr. Harbison share his remarkable journey as the second individual ever to receive the BiVACOR Total Artificial Heart. His courage, along with his family's unwavering support, is instrumental in advancing our progress in the clinic and driving the momentum of this early feasibility study. Watch the story on NBC News: https://lnkd.in/efbaqqdY.
关于我们
BiVACOR? is a clinical-stage medical device company pioneering the development of a long-term therapy for patients with biventricular heart failure. Under the expert direction of its founder and Total Artificial Heart (TAH) inventor, Daniel Timms, PhD, and the guidance of two luminaries in cardiovascular surgery, William E. Cohn, MD, and O.H. (Bud) Frazier, MD, the BiVACOR TAH is currently undergoing an FDA-approved first-in-human Early Feasibility Study (EFS). Headquartered in Huntington Beach, California, with clinical offices in Houston, Texas, and international offices in Gold Coast, Australia, BiVACOR is committed to addressing the global unmet need of patients with end-stage heart failure awaiting transplant by providing the next generation of life-extending solutions. About the BiVACOR Total Artificial Heart (TAH): The BiVACOR TAH represents a paradigm shift in artificial heart design. The size of the BiVACOR TAH is suitable for most men and women (Body Surface Area >1.4 m2). Despite its small size, the BiVACOR TAH is capable of providing enough cardiac output for an adult male undergoing exercise. Using magnetic levitation technology, the same principle used in high-speed trains, the product features a unique pump design with a single moving part: a magnetically suspended dual-sided rotor with left and right vanes positioned within two separate pump chambers, forming a double-sided centrifugal impeller that propels blood from the respective pump chambers to the pulmonary (lung) and systemic (body) circulations. The TAH has no valves or flexing ventricle chambers, with MAGLEV making pulsatile outflow possible by rapidly cycling the pump's rotor. The non-contact suspension of the rotor via MAGLEV is designed to eliminate the potential for mechanical wear and provide large blood gaps that minimize blood trauma, offering a durable, reliable, and biocompatible heart replacement.
- 网站
-
https://www.bivacor.com
BiVACOR的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Huntington Beach，California
- 类型
- 私人持股
- 创立
- 2008
- 领域
- Rotary Blood Pumps、Biomedical Engineering、Heart Failure、Total Artificial Heart、Artificial Heart、Heart Transplant和Bridge to Heart Transplant
地点
BiVACOR员工
动态
-
Stop Scrolling! Take a second and set yourself a reminder to tune into NBC News Now tonight at 8 p.m. (ET).... https://lnkd.in/dJZG-p4
Watch NBC News NOW: Live TV | NBC News
nbcnews.com
-
"Utilizing advanced maglev technology, our Total Artificial Heart brings us one step closer to providing a desperately needed option for people with end-stage heart failure who require support while waiting for a heart transplant." - Dr. Daniel Timms, Founder & CTO of BiVACOR ?? CyberGuy , Kurt Knutsson https://lnkd.in/ep2fSgVf
Mechanical artificial heart is using high-speed rail tech to keep patients alive
yahoo.com
-
The first patient received the BiVACOR Total Artificial Heart (TAH) implant on July 9 as part of the?U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS). On July 17, eight days following the BiVACOR TAH implant, a donor heart became available and was transplanted into the patient, removing the BiVACOR TAH and meeting a goal of the EFS to evaluate the safety and performance of the BiVACOR TAH as a bridge-to-heart-transplant solution for patients living with severe biventricular heart failure or univentricular heart failure in which left ventricular assist device support is not recommended. The Texas Heart Institute ?? ScienceAlert, Carly Cassella https://lnkd.in/g48-izrc
World First: Heart Made From Titanium Kept a Man Alive For Days
sciencealert.com
-
The successful implantation of the BiVACOR Total Artificial Heart marks a new era in cardiac care, offering hope to thousands of patients awaiting heart transplants. ?? ABC News, Good Morning America https://lnkd.in/gvXaCxPx
Video Doctors implant artificial heart in patient awaiting transplant
abcnews.go.com
-
“We anticipate the BiVACOR Total Artificial Heart may eventually save numerous lives, as well as improve the quality of life for patients who otherwise have no alternative therapy available.” - Dr. Alexis Shafii, Surgical Director of Heart Transplantation at Baylor St. Luke’s Medical Center and Associate Professor of Surgery, Cardiothoracic Transplant & Circulatory Support at?Baylor College of Medicine ?? The Texas Heart Institute, St. Luke's Health, Baylor College of Medicine ?? IGN Entertainment, Anthony Wood https://lnkd.in/dhJafKjH
Surgeons Implant Maglev-Powered Titanium Heart in Human Patient For the First Time - IGN
ign.com
-
"I would be remiss without calling out the patient and his family for their bravery and commitment to advancing this field. It takes an incredibly thoughtful, courageous person to say, “I’ll be the first to have my heart removed and have a mechanical device put in.” He has our admiration for his willingness to listen to the story and take that first step. He’s opened the door for a lot of people across the world who may not have access to a viable potentially long-term option for a device." - Joseph G. Rogers, M.D., President and CEO of The Texas Heart Institute and National Principal Investigator ??Healio, Scott Buzby https://lnkd.in/gqua55Qh
Q&A: New class of total artificial heart implanted successfully for first time
healio.com
-
“The first thing [the patient] said when the breathing tube came out was: ‘I feel great,’” Rogers told Healthcare Brew. Seven days after the surgery, the patient walked about one-tenth of a mile, according to an emailed statement. While active, the titanium heart pumped 12 liters of blood flow per minute, which is similar to a human heart’s capabilities. The Texas Heart Institute Joseph G. Rogers, M.D. https://lnkd.in/gEqt6eax ?? Morning Brew, Healthcare Brew, Cassie McGrath
Texas Heart Institute implants first BiVacor Total Artificial Heart
healthcare-brew.com
-
“This is an amazing advancement as the BiVACOR Total Artificial Heart (TAH) may offer hope for countless patients who suffer from end-stage heart failure. This device may serve as a life-saving bridge to a heart transplant; future studies may prove its potential as a long-term pump that can effectively serve as a total replacement for a patient’s heart. We anticipate the BiVACOR TAH may eventually save numerous lives, as well as improve the quality of life for patients who otherwise have no alternative therapy available.” - Dr. Alexis Shafii, Surgical Director of Heart Transplantation at Baylor St. Luke’s Medical Center and Associate Professor of Surgery, Cardiothoracic Transplant & Circulatory Support at?Baylor College of Medicine The Texas Heart Institute St. Luke's Health ?? The Independent Vishwam Sankaran (they/them) https://lnkd.in/gkvCTcxQ
Breakthrough metal heart keeps man alive for days in world first
independent.co.uk
-
“It is rewarding to see this result and have the BiVACOR Total Artificial Heart (TAH) perform as expected. This successful outcome is a testament to the years of dedication and innovation invested in this project. The patient continues to do well through their recovery, demonstrating the potential impact of the BiVACOR TAH on the future of heart failure treatment.” - Joseph G. Rogers, M.D., President and Chief Executive Officer of The Texas Heart Institute and National Principal Investigator of the research. ?? The Texas Heart Institute ?? The Sydney Morning Herald, amanda hooton https://lnkd.in/g99Kibfg #cardiology #heartfailure #heartdisease #medicaldevice #medtech
‘Can I get a soda?’ First words from historic artificial heart recipient
smh.com.au